Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene

11-Jun-2007

Agilent Technologies Inc. announced it has completed the acquisition of Stratagene Corp., a developer, manufacturer and marketer of specialized life science research and diagnostic products. Agilent expects this strategic acquisition to accelerate its growth in life sciences through a complementary product portfolio and strong market reach into academia and government.

Agilent announced the definitive agreement to acquire Stratagene on April 6, 2007. The company paid approximately $250 million for Stratagene, or $10.94 per share of common stock. Completion of this acquisition will have no impact on Agilent's earnings-per-share guidance. Agilent's revenue guidance for the third quarter is now $1.38 billion to $1.42 billion.

The Stratagene acquisition is expected to strengthen Agilent's life science offerings in genomics and proteomics, particularly in academia and government where Stratagene products and market leadership are well recognized. Meanwhile, Agilent's sales channel strength in the pharmaceutical market provides additional opportunities for expanding the reach of Stratagene's portfolio of reagents and instruments.

Other news from the department business & finance

These products might interest you

Micro-Dx™ CE IVD

Micro-Dx™ CE IVD by Molzym

Fully automated from sample to PCR analysis

Rapid identification of bacteria and fungi without time-consuming cultivation

DNA extraction kits
DNA-free Taq Polymerases and Mastermixes

DNA-free Taq Polymerases and Mastermixes by Molzym

DNA-free reagents for unrivalled sensitivity in molecular biology

Purity that makes the difference

PCR accessories
Greener Alternative Products

Greener Alternative Products by Merck Life Science

Sustainable laboratory products for environmentally conscious research

Over 2,500 ecological alternatives to reduce your laboratory footprint

consumables
CellGenix® Growth Factors and Cytokines

CellGenix® Growth Factors and Cytokines by Sartorius

Recombinant growth factors without animal products

Optimised cell culture for T cells and MSCs in gene therapy

reagents
Recombumin® Elite

Recombumin® Elite by Sartorius

ICHQ7 cGMP-compliant albumin for biotechnological applications

Increase consistency and safety for gene therapies and vaccines

reagents
DNA/RNA Shield™ SafeCollect Collection Kits

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research

Sample collection devices for simple & safe at-home testing

Best user experience for secure self-collection

kits
Loading...

Most read news

More news from our other portals

So close that even
molecules turn red...